Insider Transactions in Q1 2026 at New Amsterdam Pharma CO N.V. (NAMS)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Kamp Hilde Johanna Van Der |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+24.71%
|
-
|
|
Jan 07
2026
|
Louis G Lange |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+24.71%
|
-
|
|
Jan 07
2026
|
Mark C. Mc Kenna |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+24.71%
|
-
|
|
Jan 07
2026
|
John W Smither |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+24.71%
|
-
|
|
Jan 07
2026
|
William Lewis |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+24.71%
|
-
|
|
Jan 07
2026
|
Michael H. Davidson Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+14.98%
|
-
|
|
Jan 07
2026
|
Michael H. Davidson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,582
-2.97%
|
-
|
|
Jan 07
2026
|
Adele M. Gulfo |
BUY
Grant, award, or other acquisition
|
Direct |
3,400
+19.25%
|
-
|
|
Jan 07
2026
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+20.49%
|
-
|
|
Jan 07
2026
|
Mayur Ian Somaiya Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,500
+30.4%
|
-
|
|
Jan 07
2026
|
Louise Frederika Kooij Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+33.01%
|
-
|
|
Jan 05
2026
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,000
-7.55%
|
$198,000
$33.25 P/Share
|
|
Jan 05
2026
|
Mayur Ian Somaiya Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,118
-13.47%
|
$168,894
$33.25 P/Share
|
|
Jan 05
2026
|
Louise Frederika Kooij Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,647
-17.65%
|
$87,351
$33.25 P/Share
|